Estradiol VagiCap: Phase III started

TherapeuticsMD began the 12-week, double-blind, placebo-controlled, U.S. Phase III Rejoice Trial to evaluate 4, 10 and 25 Ug VagiCap given intravaginally in about 700 postmenopausal women with moderat...